Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pietrantonio

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
ESMO Open|June 24, 2025
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trialD Ciardiello, L Boscolo Bielo, F Pietrantonio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglectedF Pietrantonio, F Di Nicolantonio, A B Schrock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2024
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerM Ambrosini, B Rousseau, P Manca, et al.
ESMO Open|March 19, 2025
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trialD Ciardiello, L Boscolo Bielo, S Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2024
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONOA Raimondi, S Lonardi, S Murgioni, et al.
ESMO Open|October 29, 2025
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapyL Boscolo Bielo, S Napolitano, A Avallone, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
ESMO Open|June 24, 2025
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trialD Ciardiello, L Boscolo Bielo, F Pietrantonio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2018
RET fusions in a small subset of advanced colorectal cancers at risk of being neglectedF Pietrantonio, F Di Nicolantonio, A B Schrock, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 22, 2024
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancerM Ambrosini, B Rousseau, P Manca, et al.
ESMO Open|March 19, 2025
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trialD Ciardiello, L Boscolo Bielo, S Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2024
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONOA Raimondi, S Lonardi, S Murgioni, et al.
ESMO Open|October 29, 2025
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapyL Boscolo Bielo, S Napolitano, A Avallone, et al.
Pageof 8